Re: [Biopython] Support for Xdna, SnapGene and GCK formats
Peter Cock <[email protected]>
| Newsgroups | gmane.comp.python.bio.general |
|---|---|
| Message-ID | <CAKVJ-_5sde0KsZ2zXvL0oLF=3EGVkWZxhN4gHStbwz5fSfUZtA@mail.gmail.com> |
Damien's pull request is here: https://github.com/biopython/biopython/pull/2204 Peter On Thu, Aug 1, 2019 at 1:29 PM Peter Cock <[email protected]> wrote: > > On Thu, Aug 1, 2019 at 1:19 PM Damien Goutte-Gattat > <[email protected]> wrote: > > > > On Thu, Aug 01, 2019 at 10:01:22AM +0100, Peter Cock wrote: > > >> All the GCK files I have come from the "Drosophila Gateway Vector > > >> Collection" [1]; those files are not explicitly released under any free > > >> license (in fact there are no license terms at all), so I don't think we > > >> could bundle even one of them with the Biopython's source code, even if > > >> it is just to serve as a test file. > > > > > >The website [1] had a fairly liberal copyright statement at the bottom, > > >suggesting a sample file could be used with attribution (e.g. in the git > > >check in comment and where the test or example code used it)? > > > > The notice states "You are free to use the information contained on this > > page for non-profit purpose [...]". I am not sure this would be > > compatible with either the 3-clause BSD license or the Biopython License > > Agreement (neither of them excluding any kind of for-profit use). > > > > I am also slightly concerned by the following statement: "Portions of > > the material contained in the Drosophila Gateway Vector collection are > > subject to international patents [...]". I guess this refers to the > > vectors themselves and not merely to files containing their sequences, > > but I wonder if that could be subject to interpretation. > > > > Obviously I am no lawyer, so maybe I am just worrying too much. :) > > Sadly I think you are right. I was thinking just about the immediate (and > to me clearly non-profit) step of validating Biopython functionality - there > is definitely a problem in redistribution to anyone using Biopython in a > for-profit setting, unless one sample file is judged fair use (and that is > a legal grey area). > > > >Damien, you evidently know a lot more about email headers etc than me. > > >Are you also familiar with mailman, and how it might be better configured > > >on this specific point? > > > > Yes. > > > > Basically there's two options. > > > > ... > > > > Unfortunately, `from_is_list` has been introduced in Mailman 2.1.16 and > > `dmarc_moderation_action` in Mailman 2.1.18, but mailman.open-bio.org is > > running Mailman 2.1.15, so an upgrade would be needed before we can > > adopt that approach. > > That seems worth looking at - I will forward this to the OBF mailman team. > > Thank you, > > Peter _______________________________________________ Biopython mailing list - [email protected] https://mailman.open-bio.org/mailman/listinfo/biopython